PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 143.00
+3.00 (2.14%)
Jun 3, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 5.17 billion as of June 3, 2026. Its market cap has decreased by -37.15% in one year.
Market Cap
5.17B
Enterprise Value
2.72B
Revenue
711.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
143.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 5.17B, a decrease of -70.99%. That is a compound annual growth rate of -47.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 5.17B | -10.14% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kubota Pharmaceutical Holdings | 6.69B |
| StemCell Institute | 6.63B |
| CellSource | 6.39B |
| Soiken Holdings | 6.30B |
| TMS Co., Ltd. | 5.87B |
| Noile-Immune Biotech | 5.85B |
| Chiome Bioscience | 5.52B |
| Kohjin Bio | 5.31B |